Skip to main content
Other
Vtesse VTS301 Study. Prospective, Randomized, Double-Blind, Sham-Controlled Trial of
Department of Pediatrics
  • Sameh Morkous, MD, FAAN, Lehigh Valley Health Network
Publication/Presentation Date
10-1-2015
Abstract

The purpose of this research study is to determine if a drug called 2-hydroxypropyl- β-cyclodextrin (VTS-270) will keep your child with NPC1 from getting sicker.

Comments

Study date: October 2015 - Present.

Document Type
Research
Citation Information
Sameh Morkous. "Vtesse VTS301 Study. Prospective, Randomized, Double-Blind, Sham-Controlled Trial of" (2015)
Available at: http://works.bepress.com/sameh_morkous_lvhn/13/